World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
117
Citations
44854
World Ranking
4233
National Ranking
2317

Mark S. Soloway publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Mark S. Soloway sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 777 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Mark S. Soloway D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Mark S. Soloway sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 117 D-Index — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Mark S. Soloway is affiliated with Memorial Hospital of South Bend in the United States. Their research predominantly focuses on medicine, with a particular emphasis on surgery, pulmonary and respiratory medicine, urology, oncology, and pathology and forensic medicine.

The main topics covered in their work include bladder and urothelial cancer treatments, urinary and genital oncology studies, renal cell carcinoma treatment, urological disorders and treatments, esophageal cancer research and treatment, prostate cancer diagnosis and treatment, and epigenetics and DNA methylation.

Frequent co-authors collaborating with Mark S. Soloway include Ashish M. Kamat, Neil A. Abrahams, Soum D. Lokeshwar, Wei Shen Tan, and Peter C. Black.

Publications by Mark S. Soloway have appeared in several prominent venues, notably:

  • Bladder Cancer
  • European Urology
  • The Journal of Urology
  • Urology Practice
  • European Urology Oncology

Selected recent papers by Mark S. Soloway include:

  • International Bladder Cancer Group Consensus Statement on Clinical Trial Design for Patients with Bacillus Calmette-Guérin-exposed High-risk Non-muscle-invasive Bladder Cancer, 2021, European Urology
  • Risk-adapted management of low-grade bladder tumours: recommendations from the International Bladder Cancer Group (IBCG), 2020, British Journal of Urology
  • Best Practices to Optimise Quality and Outcomes of Transurethral Resection of Bladder Tumours, 2020, European Urology Oncology
  • Transurethral Resection of Bladder Tumour: The Neglected Procedure in the Technology Race in Bladder Cancer, 2020, European Urology
  • Bladder-sparing Therapy for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection, 2024, European Urology

Best Publications

  • Comprehensive molecular characterization of urothelial bladder carcinoma

    John N Weinstein;Rehan Akbani;Bradley McIntosh Broom;Wenyi Wang

  • Superficial Bladder Cancer: Progression and Recurrence

    Niall M. Heney;Susan Ahmed;Malachi J. Flanagan;William Frable

  • Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer.

    Donald L. Lamm;Ad P.M. Van Der Meijden;Alvaro Morales;Stanley A. Brosman

  • Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan

    Mark S. Soloway;Stephen W. Hardeman;David Hickey;Barbara Todd

  • Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the radiation therapy oncology group

    Miljenko V. Pilepich;William T. Sause;William U. Shipley;John M. Krall

  • Active Surveillance for Prostate Cancer: A Systematic Review of the Literature

    Marc A. Dall’Era;Peter C. Albertsen;Christopher Bangma;Peter R. Carroll

  • INCIDENCE, ETIOLOGY, LOCATION, PREVENTION AND TREATMENT OF POSITIVE SURGICAL MARGINS AFTER RADICAL PROSTATECTOMY FOR PROSTATE CANCER

    Jeff A. Wieder;Mark S. Soloway

  • NEOADJUVANT ANDROGEN ABLATION BEFORE RADICAL PROSTATECTOMY IN cT2bNxMo PROSTATE CANCER: 5-YEAR RESULTS

    Mark S. Soloway;Kapil Pareek;Rooholiah Sharifi;Zev Wajsman

  • Use of a New Tumor Marker, Urinary NMP22, in the Detection of Occult or Rapidly Recurring Transitional Cell Carcinoma of the Urinary Tract Following Surgical Treatment

    Mark S. Soloway;Joseph V. Briggman;Gennaro A. Carpinito;Gerald W. Chodak

  • ICUD-EAU international consultation on bladder cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder

    Georgios Gakis;Jason Efstathiou;Seth P. Lerner;Michael S. Cookson

  • Detection of bladder cancer using a point-of-care proteomic assay.

    H. Barton Grossman;Edward Messing;Mark Soloway;Kevin Tomera

  • Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer.

    Michael F. Sarosdy;Paul Schellhammer;Gary Bokinsky;Paul Kahn

  • A Randomized, Placebo-Controlled Multicenter Study of the Efficacy and Safety of Terazosin in the Treatment of Benign Prostatic Hyperplasia

    Herbert Lepor;Stephen Auerbach;Anthony Puras-Baez;Perinchery Narayan

  • A Review of Current Guidelines and Best Practice Recommendations for the Management of Nonmuscle Invasive Bladder Cancer by the International Bladder Cancer Group

    Maurizio Brausi;J. Alfred Witjes;Donald Lamm;Raj Persad

  • Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms

    William M. Murphy;William M. Murphy;Mark S. Soloway;Mark S. Soloway;Alina F. Jukkola;Alina F. Jukkola;William N. Crabtree;William N. Crabtree

  • Definitions, End Points, and Clinical Trial Designs for Non–Muscle-Invasive Bladder Cancer: Recommendations From the International Bladder Cancer Group

    Ashish M. Kamat;Richard J. Sylvester;Andreas Böhle;Joan Palou

  • Tumor-associated Hyaluronic Acid: A New Sensitive and Specific Urine Marker for Bladder Cancer

    Vinata B. Lokeshwar;Can Öbek;Mark S. Soloway;Norman L. Block

  • Careful Selection and Close Monitoring of Low-Risk Prostate Cancer Patients on Active Surveillance Minimizes the Need for Treatment

    Mark S. Soloway;Cynthia T. Soloway;Ahmed Eldefrawy;Kristell Acosta

  • Urothelial susceptibility to tumor cell implantation: influence of cauterization.

    Mark S. Soloway;Steven Masters

  • Hexaminolevulinate Guided Fluorescence Cystoscopy Reduces Recurrence in Patients With Nonmuscle Invasive Bladder Cancer

    Arnulf Stenzl;Maximilian Burger;Yves Fradet;Lance A. Mynderse

Frequent Co-Authors

J. Alfred Witjes
J. Alfred Witjes Radboud University
Nicholas J. Vogelzang
Nicholas J. Vogelzang University of Nevada Reno
Paul F. Schellhammer
Paul F. Schellhammer Eastern Virginia Medical School
Ashish M. Kamat
Ashish M. Kamat The University of Texas MD Anderson Cancer Center
H. Barton Grossman
H. Barton Grossman The University of Texas MD Anderson Cancer Center
Arnulf Stenzl
Arnulf Stenzl University of Tübingen
Joseph A. Smith
Joseph A. Smith Vanderbilt University Medical Center
Gerald P. Murphy
Gerald P. Murphy Roswell Park Cancer Institute
Victor E. Reuter
Victor E. Reuter Memorial Sloan Kettering Cancer Center
Frank J. Penedo
Frank J. Penedo University of Miami

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring allied health and healthcare management degrees can open diverse career pathways for those interested in medicine or health sciences. For nurses aiming to advance their clinical expertise, rn to np programs provide a streamlined route to becoming a nurse practitioner. These bridge programs help registered nurses progress to advanced practice roles efficiently and often offer flexible online options.

For individuals passionate about health promotion and wellness, pursuing an online bachelor's in nutrition can be a stepping stone to careers in dietetics, consulting, or further graduate study. Many programs now offer a fully online curriculum, making it easier for students to balance studies with other commitments.

Those interested in healthcare leadership should consider which online healthcare degree programs are recognized for their accreditation by cahme? Ensuring your program is CAHME-accredited not only boosts employment prospects but also assures rigorous, industry-approved training.

Finally, rn to bsn programs with no clinicals provide a convenient option for nurses seeking advancement without the burden of additional in-person clinical requirements. These programs can help you qualify for higher-level roles or serve as a bridge to graduate study.

Best Scientists Citing Mark S. Soloway

Trending Scientists

Recently Published Articles